Resuscitation of patients with metastatic cancer. Is transient benefit still futile?
Faber-Langendoen, K.
Archives of Internal Medicine 151(2): 235-239
1991
ISSN/ISBN: 0003-9926 PMID: 1842666 Document Number: 378390
Document emailed within 1 workday
Related Documents
Dudley, N.J. 1994: Resuscitation and patients' view. Futile treatment need not be offered Bmj 309(6951): 409Saeki, T. 2006: Clinical benefit of S-1 in metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(Suppl 1): 202-206
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Ratanatharathorn, V.; Sirachainan, E.; Jirajarus, M.; Sirilerttrakul, S. 2000: Clinical activity and benefit of irinotecan (CPT-11) in patients with metastatic colorectal carcinoma pre-treated with fluorouracil-based chemotherapy Journal of the Medical Association of Thailand 83(10): 1187-1195
Markson, L.E. 1993: Critically ill cancer patients: benefit and expense JAMA 269(21): 2738-2739
Stewart, K.; Bacon, M.; Bowker, L. 1998: What investigations and procedures do patients in hospices want. Patients with untreatable cancer almost never survive cardiopulmonary resuscitation Bmj 316(7138): 1166-1167
Ghaemmaghami, F.; Hassanzadeh, M.; Karimi-Zarchi, M.; Modari-Gilani, M.; Behtash, A.; Mousavi, N. 2010: Centralization of ovarian cancer surgery: do patients benefit? European Journal of Gynaecological Oncology 31(4): 429-433
Incorvaia, L.; Badalamenti, G.; Rini, G.; Arcara, C.; Fricano, S.; Sferrazza, C.; Di Trapani, D.; Gebbia, N.; Leto, G. 2007: MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone Anticancer Research 27(3b): 1519-1525
Watanabe, T.; Sawada, T.; Kubota, Y.; Ooya, M.; Masaki, T.; Sameshima, S.; Shinozaki, M.; Tsuno, N.; Uchiyama, M.; Sakaguchi, M. 1992: Continuous intra-arterial infusion chemotherapy in colorectal cancer patients with nonresectable metastatic liver cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(10 Suppl): 1515-1518
Crowell, E.B.; Higa, G.M. 1993: The chemohormonal therapy of metastatic melanoma: possible benefit of tamoxifen West Virginia Medical Journal 89(6): 233-235
Goto, S.; Shirotani, N.; Hatakeyama, M.; Tagami, C.; Arakawa, H.; Kuwata, E.; Noguchi, K.; Egawa, K. 2002: Clinical benefit of non-toxic therapy in patients with advanced cancer (opinion) Anticancer Research 22(4): 2461-2464
Bi, Y.-M.; Chen, X.-Z.; Jing, C.-K.; Zhou, R.-B.; Gao, Y.-F.; Yang, L.-B.; Chen, X.-L.; Yang, K.; Zhang, B.; Chen, Z.-X.; Chen, J.-P.; Zhou, Z.-G.; Hu, J.-K. 2014: Safety and survival benefit of surgical management for elderly gastric cancer patients Hepato-Gastroenterology 61(134): 1801-1805
2006: NSABP study confirms oncotype DX predicts chemotherapy benefit in breast cancer patients Oncology 20(7): 789-790
Alsan Cetin, I.; Akgun, Z.; Atasoy, B.M.; Fulden Yumuk, P.; Abacioglu, U. 2013: Who may benefit from prophylactic cranial irradiation amongst stage III non-small cell lung cancer patients? Journal of BUON: Official Journal of the Balkan Union of Oncology 18(2): 453-458
Girard, P.; Suresh, R.; Cosserat, J.; Czitrom, D.; Le Guillou, J.-L.; Leblanc, I.; Strauss, C.; Stern, J.-B. 2008: Futile D-dimer testing in hospitalized patients--description, interpretation, improvements Thrombosis and Haemostasis 100(6): 1209-1211
Vrdoljak, E.; Omrcen, T.; Boban, M.; Hrepic, D. 2008: Capecitabine and mitomycin-C in the therapy of pretreated patients with metastatic colorectal cancer: single center retrospective study with 36 patients Journal of BUON: Official Journal of the Balkan Union of Oncology 13(4): 513-518
Ichikawa, Y.; Goto, A.; Kobayashi, N.; Ota, M.; Tokuhisa, M.; Ishibez, A.; Watanabe, J.; Watanabe, K.; Ishikawa, T.; Tanaka, K.; Akiyama, H.; Fujii, S.; Endo, I. 2013: Does resection of primary lesions show survival benefit for stage IV colorectal cancer patients with unresectable metastases? Hepato-Gastroenterology 60(128): 1945-1949
2011: Imatinib and inoperable or metastatic gastrointestinal stromal tumours. Longer follow-up confirms the overall survival benefit Prescrire International 20(114): 61-63
Yang, J.-L.; Jackson, P.; Yu, Y.; Russell, P.J.; Markovic, B.; Crowe, P.J. 2002: Expression of the KAI1 metastasis suppressor gene in non-metastatic versus metastatic human colorectal cancer Anticancer Research 22(6a): 3337-3342
Amrein, P.C.; Coleman, M.; Richards, F.; Poulin, R.F.; Bernhardt, B.; Ginsberg, S.J.; Green, M.R.; Morrison, A.; Cortes, E.; Kiang, D.; Weinberg, V.; Wood, W.C. 1982: Phase Ii study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study Cancer Treatment Reports 66(5): 1211-1213